Skip to main content

Table 3 Univariate Cox Regression Models for Time to 1-Year Composite Outcome in the Prospective Cohort, Stratified by Heart Failure

From: Quantification of lung water in heart failure using cardiovascular magnetic resonance imaging

Univariate Predictors

Patients with or at risk for HF

(N = 203, 34 events)

Only Patients with HF

(N = 121, 28 events)

 

HR

95% CI

p-value

HR

95% CI

p-value

Age at CMR, 10 year

1.9

(1.3, 2.8)

< 0.001

1.8

(1.2,2.6)

0.004

Female gender

1.4

(0.7, 2.8)

0.31

1.8

(0.8, 3.8)

0.13

BMI, 1 kg/m2

1.0

(0.9, 1.1)

0.75

0.9

(0.9. 1.0)

0.06

Current smoker

1.0

(0.4, 2.9)

0.96

0.6

(0.2. 2.7)

0.54

Diabetes

1.3

(0.7, 2.6)

0.42

1.2

(0.6. 2.6)

0.62

Hypertension

0.7

(0.3, 1.5)

0.4

0.9

(0.4. 1.9)

0.77

CAD/MI

1.2

(0.6, 2.4)

0.58

0.9

(0.4. 1.8)

0.69

Atrial Fibrillation

1.3

(0.6, 2.6)

0.48

0.9

(0.4. 1.9)

0.73

COPD

1.7

(0.8, 3.8)

0.18

1.3

(0.5, 3.0)

0.58

History of heart failure

3.5

(1.4, 8.4)

0.006

na

na

na

NYHA class III or IV

4.1

(2.0, 8.2)

< 0.001

2.9

(1.4, 6.2)

0.005

Beta blocker at baseline

3.1

(1.2, 8.0)

0.02

1.4

(0.4, 4.5)

0.62

ACEi or ARB at baseline

1.2

(0.5, 3.1)

0.71

0.9

(0.3, 2.8)

0.94

Loop diuretic at baseline

2.4

(1.2, 4.8)

0.02

1.4

(0.6, 3.3)

0.42

Systolic BP, 10 mmHg

1.0

(0.8, 1.1)

0.56

1.1

(0.9. 1.3)

0.56

BNP, 100 pg/ml

1.2

(1.1, 1.3)

< 0.001

1.2

(1.1, 1.3)

< 0.001

Creatinine, 10 umol/L

1

(1.0, 1.2)

0.033

1.0

(0.9, 1.1)

0.53

LVEF, 10%

0.9

(0.7, 1.1)

0.35

1.1

(0.9, 1.5)

0.43

Lung water density > 20.8%

2.6

(1.3, 5.6)

0.005

2.6

(1.3, 5.6)

0.01

  1. Composite outcome: death, cardiovascular hospitalization or cardiovascular emergency department visit
  2. Abbreviations – HF heart failure, HR hazard ratio, CI confidence interval, CMR cardiovascular magnetic resonance imaging, BMI body mass index, BP blood pressure, NYHA New York Heart Association, CAD/MI coronary artery disease/myocardial infarction, COPD chronic obstructive pulmonary disease, ACEi angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker, BNP b-type natriuretic peptide, LVEF left ventricular ejection fraction
  3. BNP, and creatinine were missing for 9, and 5 patients, respectively. Medians by patient subgroup were used to impute missing values